Sarah Meibusch, a Partner at OneVentures who heads the firm's healthcare pillar. See sector focus and contact routes.
Sarah Meibusch, a Partner at OneVentures who heads the firm's healthcare pillar, invests in later-stage life sciences companies developing transformative technologies with global potential, typically deploying 10–25 million AUD per deal. She focuses on the healthcare and life sciences sectors, avoiding super early-stage ventures to target businesses with sound models and strong forecasts that can achieve a 10x multiple within the fund horizon. Her notable portfolio involvement includes serving as Chair of Axial Therapeutics and Vaxxas, and as a Board Member for Kira Biotech. OneVentures' distinctive thesis centers on scaling technology and healthcare companies through growth equity and credit, leveraging global executional experience to drive innovation to market.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Brisbane.
Investors like Sarah Meibusch · Full investor directory · Investor access · Company funding database